Vanta Bioscience allots equity shares via preferential route

Vanta Bioscience Limited (BSE: 540332) announced the allotment of 800,000 equity shares to promoters on a preferential basis at an issue price of INR 50 per share, as approved by the board in a meeting held on May 6, 2025. This allotment follows shareholder approval granted in an extraordinary general meeting on January 4, 2025, and the receipt of in-principle approval from BSE Ltd. The move is in compliance with the Companies Act, 2013 and SEBI (ICDR) Regulations. 400,000 shares each were allotted to Mr. Dopesh Raja Mulakala, Promoter and Managing Director, and Mr. S Chandra Sekhar Rao, Promoter. The allotments are made based on the terms mentioned in the EGM notice, which was held on January 4, 2025.